LYRA - Lyra Therapeutics  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LYRA is currently covered by 5 analysts with an average price target of $15.15. This is a potential upside of $6.44 (73.94%) from yesterday's end of day stock price of $8.71.

Lyra Therapeutics 's activity chart (see below) currently has 4 price targets and 19 ratings on display. The stock rating distribution of LYRA is 62.5% BUY and 37.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.56% with an average time for these price targets to be met of 575.17 days.

Highest price target for LYRA is $16, Lowest price target is $16, average price target is $8.83.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 10-Jun-2025. First documented stock forecast 26-May-2020.

Best performing analysts who are covering LYRA - Lyra Therapeutics :

Jason Gerberry Matthew Caufield Robert Hazlett Louise Chen Dennis Ding Justin Zelin

Currently out of the existing stock ratings of LYRA, 10 are a BUY (62.5%), 6 are a HOLD (37.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$16

$7.35 (84.97%)

$2

1 months 4 days ago
(10-Jun-2025)

5/6 (83.33%)

$0.5 (3.23%)

422

Buy

10 months 29 days ago
(15-Aug-2024)

1/1 (100%)

$9 (150.00%)

1105

Hold

$0.5

$-8.15 (-94.22%)

1 years 2 months 7 days ago
(07-May-2024)

1/1 (100%)

$0.08 (19.05%)

386

Hold

$15

1 years 2 months 8 days ago
(06-May-2024)

1/1 (100%)

$11.36 (312.09%)

605

Buy

$10

$1.35 (15.61%)

$11

1 years 2 months 12 days ago
(02-May-2024)

6/6 (100%)

$5.37 (115.98%)

933

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LYRA (Lyra Therapeutics ) average time for price targets to be met?

On average it took 575.17 days on average for the stock forecasts to be realized with a an average price target met ratio 80.56

Which analyst has the current highest performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JASON GERBERRY

Which analyst has the current lower performing score on LYRA (Lyra Therapeutics ) with a proven track record?

JUSTIN ZELIN

Which analyst has the most public recommendations on LYRA (Lyra Therapeutics )?

Jason Gerberry works at BAML and has 5 price targets and 3 ratings on LYRA

Which analyst is the currently most bullish on LYRA (Lyra Therapeutics )?

Matthew Caufield with highest potential upside - $7.35

Which analyst is the currently most reserved on LYRA (Lyra Therapeutics )?

Dennis Ding with lowest potential downside - -$8.15

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?